174 related articles for article (PubMed ID: 36387060)
21. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
23. [Guidelines for the treatment of Hansen's disease in Japan (third edition)].
Goto M; Nogam R; Okano Y; Gidoh M; Yotsu R; Ishida Y; Kitajima S; Kai M; Ishii N; Ozaki M; Hatano K; ;
Nihon Hansenbyo Gakkai Zasshi; 2013 Dec; 82(3):143-84. PubMed ID: 24579462
[TBL] [Abstract][Full Text] [Related]
24.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
25. Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil.
Celestino IC; Antunes DE; Santos DF; Gimenes VL; de Souza FM; Goulart IMB
Front Pharmacol; 2024; 15():1346169. PubMed ID: 38515839
[No Abstract] [Full Text] [Related]
26. Hansen's Disease.
Wathen PI
South Med J; 1996 Jul; 89(7):647-52. PubMed ID: 8685748
[TBL] [Abstract][Full Text] [Related]
27. Renaissance of Hansen's Disease in Post-Elimination Era in North India: A Retrospective Clinico-Bacteriological Study.
Hazarika N; Gupta PK; Dhanta A; Singh A; Mohanty A; Gupta P
Cureus; 2021 Aug; 13(8):e17514. PubMed ID: 34603886
[TBL] [Abstract][Full Text] [Related]
28. Multidrug therapy in hospitalised leprosy cases.
Tiwari VD; Tutakne MA; Singh G; Dutta RK
Indian J Lepr; 1988 Jan; 60(1):71-6. PubMed ID: 3204277
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
Lim JT; Tan T
Lepr Rev; 1993 Jun; 64(2):136-42. PubMed ID: 8341116
[TBL] [Abstract][Full Text] [Related]
30. [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].
Goulart IM; Arbex GL; Carneiro MH; Rodrigues MS; Gadia R
Rev Soc Bras Med Trop; 2002; 35(5):453-60. PubMed ID: 12621663
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Andrade VL; Marques AB; da Cunha LH; Avelleira JR
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
33. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
34. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
35. Alternate Anti-Leprosy Regimen for Multidrug Therapy Refractory Leprosy: A Retrospective Study from a Tertiary Care Center in North India.
Narang T; Bishnoi A; Dogra S; Saikia UN; Kavita
Am J Trop Med Hyg; 2019 Jan; 100(1):24-30. PubMed ID: 30298809
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.
Piscitelli SC; Occhipinti DJ; Danziger LH; Hill C; West DP; Fischer JH
Ann Pharmacother; 1993 Dec; 27(12):1526-31. PubMed ID: 8305789
[TBL] [Abstract][Full Text] [Related]
37. Delayed Diagnosis, Leprosy Reactions, and Nerve Injury Among Individuals With Hansen's Disease Seen at a United States Clinic.
Leon KE; Jacob JT; Franco-Paredes C; Kozarsky PE; Wu HM; Fairley JK
Open Forum Infect Dis; 2016 Mar; 3(2):ofw063. PubMed ID: 27186586
[TBL] [Abstract][Full Text] [Related]
38. Hansen's disease: a vanishing disease?
Talhari S; Grossi MA; Oliveira ML; Gontijo B; Talhari C; Penna GO
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():13-6. PubMed ID: 23283447
[TBL] [Abstract][Full Text] [Related]
39. A Rare Case of Hansen's Disease Complicated by G6PD Deficiency.
Yerke Hansen P; Myers E; Rajalingam K; Labanowski M
Cureus; 2023 Aug; 15(8):e42816. PubMed ID: 37664264
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of MDT in multibacillary leprosy.
Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
